CLINICAL_TRIALS
trial_result
· 2015-01-05
Clinical Trial Update: A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105) [Phase 4]
Summary
Phase 4 pharmacokinetic study of posaconazole in lung transplant recipients was terminated; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Fungal Infection | Phase 4 | Status: TERMINATED | Results posted: 2015-01-05